Profiling sulfation/epimerization pattern of full-length heparan sulfate by NMR following cell culture 13C-glucose metabolic labeling

Glycobiology

Volumn 25, Issue 2, 2015, Pages 151-156

  Pegeot, Mathieu ^a,b,c   Sadir, Rabia ^a,b,c   Eriksson, Inger ^d   Kjellen, Lena ^d   Simorre, Jean Pierre ^a,b,c   Gans, Pierre ^a,b,c   Lortat Jacob, Hugues ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b CNRS   (France)

^c CEA GRENOBLE   (France)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

13C metabolic labeling; heparan sulfate; quantification of GlcA IdoA epimeriation; sulfation pattern

Indexed keywords

GLUCOSE C 13; HEPARAN SULFATE; RADIOPHARMACEUTICAL AGENT; SULFOTRANSFERASE; UNCLASSIFIED DRUG; GLUCOSE; HEPARITIN SULFOTRANSFERASE;

ARTICLE; CACO 2 CELL LINE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CULTURE; CELL DIFFERENTIATION; EPIMERIZATION; EPITHELIUM CELL; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; ISOTOPE LABELING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SULFATION; ANIMAL; GENE INACTIVATION; GENETICS; METABOLISM; MOUSE;

ANIMALS; CACO-2 CELLS; CARBON-13 MAGNETIC RESONANCE SPECTROSCOPY; GENE KNOCKOUT TECHNIQUES; GLUCOSE; HELA CELLS; HEPARITIN SULFATE; HUMANS; ISOTOPE LABELING; MICE; SULFOTRANSFERASES;

EID: 84941053190     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu114     Document Type: Article

References (30)

1. Bulow HE, Hobert O. 2006. The molecular diversity of glycosaminoglycans shapes animal development. Annu Rev Cell Dev Biol. 22:375-407.
2. Casu B, Lindahl U. 2001. Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem. 57:159-206.
3. Casu B, Naggi A, Torri G. 2010. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Matrix Biol. 29:442-452.
4. Delaglio F, Grzesiek S, VuisterGW, Zhu G, Pfeifer J, Bax A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 6:277-293.
5. Desai UR, Wang HM, Linhardt RJ. 1993. Specificity studies on the heparin lyases from Flavobacterium heparinum. Biochemistry. 32:8140-8145.
6. Galeotti F, Volpi N. 2013. Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides. J Chromatogr A. 1284:141-147.
7. Gallagher JT, Walker A. 1985. Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides. Biochem J. 230:665-674.
8. Guerrini M, Bisio A, Torri G. 2001. Combined quantitative (1)H and (13)C nuclear magnetic resonance spectroscopy for characterization of heparin preparations. Semin Thromb Hemost. 27:473-482.
9. Guerrini M, Naggi A, Guglieri S, Santarsiero R, Torri G. 2005. Complex glycosaminoglycans: Profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy. Analyt Biochem. 337:35-47.
10. Hagner-Mcwhirter A, Lindahl U, Li J. 2000. Biosynthesis of heparin/heparan sulphate: Mechanism of epimerization of glucuronyl C-5. Biochem J. 347 (Pt 1):69-75.
11. Huckerby TN, Nieduszynski IA, Giannopoulos M, Weeks SD, Sadler IH, Lauder RM. 2005. Characterization of oligosaccharides from the chondroitin/ dermatan sulfates. 1H-NMR and 13C-NMR studies of reduced trisaccharides and hexasaccharides. FEBS J. 272:6276-6286.
12. Kraushaar DC, Dalton S, Wang L. 2013. Heparan sulfate: A key regulator of embryonic stem cell fate. Biol Chem. 394:741-751.
13. Kreuger J, Kjellen L. 2012. Heparan sulfate biosynthesis: Regulation and variability. J Histochem Cytochem. 60:898-907.
14. Langeslay DJ, Beecher CN, Naggi A, Guerrini M, Torri G, Larive CK. 2013. Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis. Analyt Chem. 85:1247-1255.
15. Langeslay DJ, Beni S, Larive CK. 2012. A closer look at the nitrogen next door: 1H-15NNMRmethods for glycosaminoglycan structural characterization. J Magn Reson. 216:169-174.
16. Ledin J, Staatz W, Li JP, Gotte M, Selleck S, Kjellen L, Spillmann D. 2004. Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem. 279:42732-42741.
17. Lindahl U, Li JP. 2009. Interactions between heparan sulfate and proteinsdesign and functional implications. Int Rev Cell Mol Biol. 276:105-159.
18. Lortat-Jacob H, Turnbull JE, Grimaud JA. 1995. Molecular organization of the interferon gamma-binding domain in heparan sulphate. Biochem J. 310(Pt 2):497-505.
19. Ori A, Wilkinson MC, Fernig DG. 2008. The heparanome and regulation of cell function: Structures, functions and challenges. Front Biosci. 13:4309-4338.
20. Pomin VH, Sharp JS, Li X, Wang L, Prestegard JH. 2010. Characterization of glycosaminoglycans by 15N NMR spectroscopy and in vivo isotopic labeling. Analyt Chem. 82:4078-4088.
21. Ringvall M, Ledin J, Holmborn K, van Kuppevelt T, Ellin F, Eriksson I, Olofsson AM, Kjellen L, Forsberg E. 2000. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/Nsulfotransferase-1. J Biol Chem. 275:25926-25930.
22. Sadir R, Imberty A, Baleux F, Lortat-Jacob H. 2004. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem. 279:43854-43860.
23. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 21:1-26.
24. Sarrazin S, Lamanna WC, Esko JD. 2011. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. 3:1-33.
25. Shi X, Zaia J. 2009. Organ-specific heparan sulfate structural phenotypes. J Biol Chem. 284:11806-11814.
26. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH. 1998. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem. 273:12960-12966.
27. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED. 2005. The CCPN data model for NMR spectroscopy: Development of a software pipeline. Proteins. 59:687-696.
28. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL, Sykes BD. 1995. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR. 6:135-140.
29. Zaia J. 2013. Glycosaminoglycan glycomics using mass spectrometry. Mol Cell Proteomics. 12:885-892.
30. Zhang Z, McCallum SA, Xie J, Nieto L, Corzana F, Jimenez-Barbero J, Chen M, Liu J, Linhardt RJ. 2008. Solution structures of chemoenzymatically synthesized heparin and its precursors. J Am Chem Soc. 130:12998-13007.